ALKBH5 has been reported to be dysregulated with either tumor-promoting or tumor-inhibiting roles in various cancer types, including pancreatic cancer, lung cancer, breast cancer and HCC [26]. This evidence concerns the gene ALKBH5 and breast carcinoma.